Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
E. Groth (Großhansdorf, Germany), M. Weber (Princeton, United States of America), T. Bahmer (Kiel, Germany), F. Pedersen (Großhansdorf, Germany), A. Kirsten (Großhansdorf, Germany), D. Börnigen (Hamburg, Germany), K. Rabe (Großhansdorf, Germany), H. Watz (Großhansdorf, Germany), O. Ammerpohl (Ulm, Germany), T. Goldmann (Borstel, Germany). Deconvolution of the sputum transcriptome and methylome by quadratic programming in asthma and COPD. 693

Member's Comments

No comment yet.

Related content which might interest you: Multi-level differential network analysis of COPD exacerbations Source: Eur Respir J, 50 (3) 1700075; 10.1183/13993003.00075-2017 Year: 2017 LSC Abstract – Multi-level differential network analysis of COPD exacerbations Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Applications of induced sputum sampling in asthma and COPD Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis Source: Eur Respir J, 51 (5) 1702173; 10.1183/13993003.02173-2017 Year: 2018 A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Optimization of diagnostics and differential diagnostics of bronchial asthma and COPD Source: Eur Respir J 2007; 30: Suppl. 51, 618s Year: 2007 Lung microbiome dynamics in COPD exacerbations Source: Eur Respir J 2016; 47: 1082-1092 Year: 2016 Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission Source: Eur Respir J, 55 (2) 1901280; 10.1183/13993003.01280-2019 Year: 2020 Quantitative proteomics on bronchial biopsies from asthma and COPD: Effects of budesonide treatment Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Ensemble machine learning for the early detection of COPD exacerbations Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Combining digital technologies to monitor asthma control and predict asthma exacerbations Source: Virtual Congress 2020 – Digital health: a brave new world? Year: 2020 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019